Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can slower dialysis fluid flow still clean blood effectively?

NCT ID NCT07360769

First seen Jan 26, 2026 · Last updated Jun 20, 2026 · Updated 24 times

Summary

This study looked at whether using a lower dialysate flow rate (300 ml/min instead of the usual 500 ml/min) affects how well dialysis cleans the blood, how quickly patients recover after treatment, and their overall quality of life. Eighty adults with end-stage kidney disease on maintenance hemodialysis took part. Each patient had one week of standard flow and one week of low flow to compare results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE (ESRD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Faculty of Medicine Alexandria University

    Alexandria, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lower dialysate flow rate (300 ml/min)

What this could lead to

If successful, this could show that using less dialysate fluid is safe and effective, potentially reducing costs and environmental waste in dialysis.

What could go wrong

This is a small, completed study with only 80 participants, so results may not apply to all kidney patients. Lower flow might reduce dialysis adequacy for some individuals.

Conditions

The condition(s) this trial relates to.

chronic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.